MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, OVID made $7,252K in revenue. -$17,414K in net income. Net profit margin of -240.13%.

Income Overview

Revenue
$7,252K
Net Income
-$17,414K
Net Profit Margin
-240.13%
EPS
-$232.47
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Revenue
7,252
Payroll and payroll-related expenses
7,765
Total direct program expenses
15,726
Other research and development expenses
2,091
Research and development
25,582
General and administrative
24,109
Total operating expenses
49,691
Loss from operations
-42,439
Other income (expense), net
25,026
Loss before provision for income taxes
-17,414
Provision for income taxes
0
Net loss
-17,414
Basic EPS
-232.47
Diluted EPS
-232.47
Basic Average Shares
1,171
Diluted Average Shares
1,171
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$17,414K Loss beforeprovision for income taxes-$17,414K Other income(expense), net$25,026K Loss from operations-$42,439K Revenue$7,252K Total operatingexpenses$49,691K Research and development$25,582K General andadministrative$24,109K Total direct programexpenses$15,726K Payroll andpayroll-related expenses$7,765K Other research anddevelopment expenses$2,091K

Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Inc. (OVID)